Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call, S A; Saag, M S; Westfall, A O; Raper, J L; Pham, S V; Tolson, J M; Hellmann, N S; Cloud, G A; Johnson, V A

Call, S A; Saag, M S; Westfall, A O; Raper, J L; Pham, S V; Tolson, J M; Hellmann, N S; Cloud, G A; Johnson, V A.

Affiliation

Call SA; Division of General Internal Medicine and Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35294-0006, USA.

J Infect Dis ; 183(3): 401-8, 2001 Feb 01.

Article in En | MEDLINE | ID: mdl-11133371

Subject(s)

Anti-HIV Agents/pharmacology; HIV Infections/drug therapy; HIV Infections/virology; HIV-1/drug effects; Reverse Transcriptase Inhibitors/pharmacology; Adult; Anti-HIV Agents/therapeutic use; CD4 Lymphocyte Count; Cohort Studies; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; HIV-1/isolation & purification; HIV-1/physiology; Humans; Male; Phenotype; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; RNA, Viral/blood; Reverse Transcriptase Inhibitors/therapeutic use; Risk Factors; Treatment Failure; Viral Load

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / HIV-1 / Reverse Transcriptase Inhibitors / Anti-HIV Agents Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: J Infect Dis Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links